Zobrazeno 1 - 10
of 93
pro vyhledávání: '"postmenopausia"'
Publikováno v:
Revista Científica CMDLT, Vol 17, Iss Suplemento (2023)
El cáncer de cuello uterino más común es el carcinoma de células escamosas, los tumores mesenquimales del cuello uterino son infrecuentes, los sarcomas cervicales son tumores malignos que se originan en el denominado tejido conectivo, que provien
Externí odkaz:
https://doaj.org/article/6c432675b7714b4db29c20c640e84653
Autor:
Jorge Castro, Mary Lares, María Gabriela Mena, Sara Brito, María Gabriela Alfonzo, Eimer Kinsley, Maricela Ramirez
Publikováno v:
Revista Digital de Postgrado, Vol 12, Iss 1 (2023)
Objetivo: Determinar la relación de triglicéridos basales, con el riesgo a desarrollar enfermedades cardiovasculares en mujeres posmenopáusicas. Método: Estudio descriptivo, observacional y transversal, donde a 31 pacientes posmenopáusicas y sin
Externí odkaz:
https://doaj.org/article/3578db48dced416b82be3804ad983b04
Autor:
Roberto Rebolledo-Cobos, Ana Caro-Freile, Raul Polo-Gallardo, Vanessa Jurado-Castro, Elsy Jabba-Molinares, Yaneth Herazo-Beltrán, Martha Mendinueta-Martínez, Luz Sarmiento-Rubiano
Publikováno v:
Revista de la Facultad de Medicina, Vol 67, Iss 2, Pp 257-263 (2019)
Introducción. La magnitud de la lipemia postprandial es un indicador de riesgo cardiovascular, en especial en mujeres con actividad hormonal reducida. Los ejercicios resistidos (ER) podrían ser un factor que influencie las concentraciones de lípid
Externí odkaz:
https://doaj.org/article/6b39f7b922b04ff3b04f19258e7302a5
Autor:
López Gavilánez E, Orces CH, Guerrero Franco K, Segale Bajaña Á, Veliz Ortega J, Bajaña Granja W
Publikováno v:
Revista de Osteoporosis y Metabolismo Mineral, Vol 10, Iss 1, Pp 7-14 (2018)
Objetivos: Conocer la prevalencia de insuficiencia de vitamina D en mujeres ecuatorianas postmenopáusicas con diabetes mellitus tipo 2, y establecer si existe correlación entre los niveles séricos de vitamina D total, las variables de control meta
Externí odkaz:
https://doaj.org/article/10de2677007f44e7a8b46359006af8b5
Autor:
Gómez Díaz, Aurora
Publikováno v:
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
Universidad de Cantabria (UC)
Antecedentes: Con la llegada de la menopausia se acelera notablemente la pérdida de masa mineral ósea, especialmente durante los cinco primeros años desde su diagnóstico en los que se puede perder hasta un 5% de masa ósea al año. La principal d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6631ca4ffdfc93c7f6777d49a6e0e46e
http://hdl.handle.net/10902/25493
http://hdl.handle.net/10902/25493
Autor:
Garcia-Yu, Irene A
Publikováno v:
GREDOS. Repositorio Institucional de la Universidad de Salamanca
instname
instname
Tesis por compendio de publicaciones
[ES] La ingesta de polifenoles ha demostrado ciertos beneficios para la salud. El objetivo de este estudio fue analizar el efecto de añadir 10 g diarios de chocolate comercial con alto porcentaje de cacao (9
[ES] La ingesta de polifenoles ha demostrado ciertos beneficios para la salud. El objetivo de este estudio fue analizar el efecto de añadir 10 g diarios de chocolate comercial con alto porcentaje de cacao (9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a57fe4ffae7c3807cef20dafc4deebf0
https://doi.org/10.14201/gredos.149472
https://doi.org/10.14201/gredos.149472
Autor:
Manuel Rosety-Rodríguez, Gabriel Fornieles, Ignacio Rosety, Antonio J. Díaz, Miguel A. Rosety, Alejandra Camacho-Molina, A. Rodríguez-Pareja, A. Tejerina, José Ramón Alvero-Cruz, Francisco J. Ordonez
Publikováno v:
Nutrición Hospitalaria, Vol 28, Iss 6, Pp 1912-1917 (2013)
Introduction: The various diagnostic classifications in the literature concur as regards the important role of abdominal obesity in the onset and progression of metabolic syndrome. Accordingly, this study was aimed at clarifying whether central obesi
Externí odkaz:
https://doaj.org/article/4b9c9236c9de426386c58e89dd6cc239
Autor:
Archila Villalobos, Natalia
Publikováno v:
Hall JE, Maki P, Sluss PM, Harlow SD, de Villiers TJ, Rebar RW, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012;19(4):387–95.
Pernas A, Pérez J. Síndrome climatérico. Caracterización y factores de riesgo. Villa Clara. 2004. Rev. Temas Estadísticos de Salud. [Internet]. 2005 [Consultado: 10 de abril de 2020]. Disponible en: http://www.sld.cu/galerias/pdf/sitios/dne/nro1_sindrome_.
Legro RS, Lin HM, Demers LM, Lloid T. Rapid maturation of the reproductive axis during perimenarche independent of body composition. J Clin Endocrinol Metab 2000;85(3):1021–25.
Lobo RA. Menopause and Aging [Internet]. Yen & Jaffe’s Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management: Eighth Edition. Elsevier; 2018. 322-356. [revisado 2020; citado 25 de octubre 2020] Disponible en: http://dx.doi.org/1.
Levin RJ, Both S, Georgiadis J, Kukkonen T, Park K, Yang CC. The Physiology of Female Sexual Function and the Pathophysiology of Female Sexual Dysfunction (Committee 13A). J Sex Med 2016;13(5):733–59.
Wright J, O’ Connor Kim. Female Sexual Dysfunction. Med Clin N Am 2015;99:607–28.
Muñoz AP, Camacho PA. Prevalencia y factores de riesgo de la disfunción sexual femenina: revisión sistemática. Rev Chil Obstet Ginecol. 2016;81(3):168–80.
Caruso S, Rapisarda AM, Cianci S. Sexuality in menopausal women. Curr Opin Psychiatry . 2016;29(6):323-30.
Nicolosi A, Paik A, Gingell C, Moreira E, Laumann EO, Wang T, et al. Sexual problems among women and men aged 40–80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res. 2004;17(1):39–57.
Laumann EO, Nicolosi A, GlasserDB, Paik A, Gingell C, Moreira E, et al. Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res . 2005;17(1):39-57.
Parekattil S, Sijo J, Ashok Agarwal. Male Infertility Contemporary Clinical Approaches, Andrology, ART & Antioxidants. Springer, 2012.
Wåhlin-jacobsen S, Kristensen E, Pedersen AT, Laessøe NC, Cohen AS, Hougaard DM, et al. Androgens and Psychosocial Factors Related to Sexual Dysfunctions in Premenopausal Women. J Sex Med. 2017;14(3):366-79.
Dennerstein L, Dudley EC, Hopper JL, Burger H. Sexuality, hormones and the menopausal transition. Maturitas. 1997;26(2):83–93.
Simon JA, Kokot-Kierepa M, Goldstein J, Nappi R. Vaginal health in the United States: results from the Vaginal Health: Insights, Views & Attitudes survey. Menopause . 2013 Oct;20(10):1043-8.
Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane Handbook for Systematic Reviews of Interventions. 2011.
Davis S, Robinson P, Jane F, White S, White M, Bell R. Intravaginal Testosterone Improves Sexual Satisfaction and Vaginal Symptoms Associated With Aromatase Inhibitors. J Clin Endocrinol Metab . 2018;103(11):4146-54.
Fernandes T, Costa-Paiva LH, Pinto-Neto AE. Efficacy of Vaginally Applied Estrogen, Testosterone, or Polyacrylic Acid on Sexual Function in Postmenopausal Women: A Randomized Controlled Trial. J Sex Med . 2014;11(5):1262-70.
Chaikittisilpa S, Soimongkol K, Jaisamrarn U. Efficacy of oral estrogen plus testosterone gel to improve sexual function in postmenopausal women. Climacteric . 2019;22(5):460-465.
Tungmunsakulchai R, Chaikittisilpa S, Snabboon T, Panyakhamlerd K, Jaisamrarn U, Taechakraichana N. Effectiveness of a low dose testosterone undecanoate to improve sexual function in postmenopausal women. BMC Womens Health . 2015;15(113):1-6.
Blümel JE, Del Pino M, Aprikian D, Vallejo S, Sarrá S, Castelo-Branco C. Effect of androgens combined with hormone therapy on quality of life in post-menopausal women with sexual dysfunction. Gynecol Endocrinol . 2008;24(12):691-95.
Dow MG, Hart DM, Forrest CA. Hormonal treatments of sexual unresponsiveness in postmenopausal women: a comparative study. Br J Obstet Gynaecol . 1983 Apr;90(4):361-6.
Kingsberg S, Shifren J, WekselmanK, Rodenberg C, Koochaki P, Derogatis L. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual. desire disorder. J Sex Med . 2007.
Shifren JF, Davis SR, Moreau M, Waldbaum A, Bouchard C, DeRogatis L, Derzko C. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study. Menopause .2006;13(5):770-79.
Panay N, Al-Azzawi F, Bouchard C, Davis SR, Eden J, Lodhi I. Testosterone treatment of HSDD in naturally menopausal women: the ADORE study. Climacteric . 2010;13(2):121-31.
Barton D, Sloan JA, Shuster LT, Gill P, Griffin P, Flynn K, Terstriep SA, et al. Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance). Support Care Cancer . 2018;26(2):643.
Archer DF,Labrie F, Bouchard C, Portman DJ, Koltun W, Cusan L. Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone). Menopause . 2015;22(9):950-63.
Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal women. J Sex Med . 2014;11(7):1766-85.
Carney A, Bancroft J, Mathews A. Combination of hormonal and psychological treatment for female sexual unresponsiveness: a comparative study. Br J Psychiatry 1978;133:339–46.
Simon J, Klaiber E, Wiita B, Bowen A, Yang HM. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women. Menopause 1999;6:138–34.
Islam R, Bell RJ, Green S, Page MJ, Davis S. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. Lancet Diabetes Endocrinol . 2019;7(10):754-66.
Gitlin N, Korner P, Yang HM. Liver function in postmenopausal women on estrogen-androgen hormone replacement therapy: a meta-analysis of eight clinical trials. Menopause 1999;6:216–24.
Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women. Menopause .2009;16(5):923-31.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Pernas A, Pérez J. Síndrome climatérico. Caracterización y factores de riesgo. Villa Clara. 2004. Rev. Temas Estadísticos de Salud. [Internet]. 2005 [Consultado: 10 de abril de 2020]. Disponible en: http://www.sld.cu/galerias/pdf/sitios/dne/nro1_sindrome_.
Legro RS, Lin HM, Demers LM, Lloid T. Rapid maturation of the reproductive axis during perimenarche independent of body composition. J Clin Endocrinol Metab 2000;85(3):1021–25.
Lobo RA. Menopause and Aging [Internet]. Yen & Jaffe’s Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management: Eighth Edition. Elsevier; 2018. 322-356. [revisado 2020; citado 25 de octubre 2020] Disponible en: http://dx.doi.org/1.
Levin RJ, Both S, Georgiadis J, Kukkonen T, Park K, Yang CC. The Physiology of Female Sexual Function and the Pathophysiology of Female Sexual Dysfunction (Committee 13A). J Sex Med 2016;13(5):733–59.
Wright J, O’ Connor Kim. Female Sexual Dysfunction. Med Clin N Am 2015;99:607–28.
Muñoz AP, Camacho PA. Prevalencia y factores de riesgo de la disfunción sexual femenina: revisión sistemática. Rev Chil Obstet Ginecol. 2016;81(3):168–80.
Caruso S, Rapisarda AM, Cianci S. Sexuality in menopausal women. Curr Opin Psychiatry . 2016;29(6):323-30.
Nicolosi A, Paik A, Gingell C, Moreira E, Laumann EO, Wang T, et al. Sexual problems among women and men aged 40–80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res. 2004;17(1):39–57.
Laumann EO, Nicolosi A, GlasserDB, Paik A, Gingell C, Moreira E, et al. Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res . 2005;17(1):39-57.
Parekattil S, Sijo J, Ashok Agarwal. Male Infertility Contemporary Clinical Approaches, Andrology, ART & Antioxidants. Springer, 2012.
Wåhlin-jacobsen S, Kristensen E, Pedersen AT, Laessøe NC, Cohen AS, Hougaard DM, et al. Androgens and Psychosocial Factors Related to Sexual Dysfunctions in Premenopausal Women. J Sex Med. 2017;14(3):366-79.
Dennerstein L, Dudley EC, Hopper JL, Burger H. Sexuality, hormones and the menopausal transition. Maturitas. 1997;26(2):83–93.
Simon JA, Kokot-Kierepa M, Goldstein J, Nappi R. Vaginal health in the United States: results from the Vaginal Health: Insights, Views & Attitudes survey. Menopause . 2013 Oct;20(10):1043-8.
Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane Handbook for Systematic Reviews of Interventions. 2011.
Davis S, Robinson P, Jane F, White S, White M, Bell R. Intravaginal Testosterone Improves Sexual Satisfaction and Vaginal Symptoms Associated With Aromatase Inhibitors. J Clin Endocrinol Metab . 2018;103(11):4146-54.
Fernandes T, Costa-Paiva LH, Pinto-Neto AE. Efficacy of Vaginally Applied Estrogen, Testosterone, or Polyacrylic Acid on Sexual Function in Postmenopausal Women: A Randomized Controlled Trial. J Sex Med . 2014;11(5):1262-70.
Chaikittisilpa S, Soimongkol K, Jaisamrarn U. Efficacy of oral estrogen plus testosterone gel to improve sexual function in postmenopausal women. Climacteric . 2019;22(5):460-465.
Tungmunsakulchai R, Chaikittisilpa S, Snabboon T, Panyakhamlerd K, Jaisamrarn U, Taechakraichana N. Effectiveness of a low dose testosterone undecanoate to improve sexual function in postmenopausal women. BMC Womens Health . 2015;15(113):1-6.
Blümel JE, Del Pino M, Aprikian D, Vallejo S, Sarrá S, Castelo-Branco C. Effect of androgens combined with hormone therapy on quality of life in post-menopausal women with sexual dysfunction. Gynecol Endocrinol . 2008;24(12):691-95.
Dow MG, Hart DM, Forrest CA. Hormonal treatments of sexual unresponsiveness in postmenopausal women: a comparative study. Br J Obstet Gynaecol . 1983 Apr;90(4):361-6.
Kingsberg S, Shifren J, WekselmanK, Rodenberg C, Koochaki P, Derogatis L. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual. desire disorder. J Sex Med . 2007.
Shifren JF, Davis SR, Moreau M, Waldbaum A, Bouchard C, DeRogatis L, Derzko C. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study. Menopause .2006;13(5):770-79.
Panay N, Al-Azzawi F, Bouchard C, Davis SR, Eden J, Lodhi I. Testosterone treatment of HSDD in naturally menopausal women: the ADORE study. Climacteric . 2010;13(2):121-31.
Barton D, Sloan JA, Shuster LT, Gill P, Griffin P, Flynn K, Terstriep SA, et al. Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance). Support Care Cancer . 2018;26(2):643.
Archer DF,Labrie F, Bouchard C, Portman DJ, Koltun W, Cusan L. Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone). Menopause . 2015;22(9):950-63.
Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal women. J Sex Med . 2014;11(7):1766-85.
Carney A, Bancroft J, Mathews A. Combination of hormonal and psychological treatment for female sexual unresponsiveness: a comparative study. Br J Psychiatry 1978;133:339–46.
Simon J, Klaiber E, Wiita B, Bowen A, Yang HM. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gonadotropin secretion, and endogenous androgen bioavailability in postmenopausal women. Menopause 1999;6:138–34.
Islam R, Bell RJ, Green S, Page MJ, Davis S. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. Lancet Diabetes Endocrinol . 2019;7(10):754-66.
Gitlin N, Korner P, Yang HM. Liver function in postmenopausal women on estrogen-androgen hormone replacement therapy: a meta-analysis of eight clinical trials. Menopause 1999;6:216–24.
Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women. Menopause .2009;16(5):923-31.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Antecedentes: Durante la postmenopausia puede experimentarse disfunción sexual multifactorial debido a la deprivación de estrógenos. La administración de testosterona ha demostrado mejorar el deseo de la mujer, sin embargo, existe controversia so
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f602970d3233c8ffaf1d65316b4affe5
https://repository.urosario.edu.co/handle/10336/33564
https://repository.urosario.edu.co/handle/10336/33564
Autor:
Martínez Muñoz, Fulgencio
Publikováno v:
REDIUMH. Depósito Digital de la UMH
instname
instname
Introducción: Se estima que una de cada tres mujeres sufrirá fracturas debido a la osteoporosis. Es después de la menopausia cuando se intensifica la pérdida de densidad mineral ósea (DMO) que se trata de paliar con medidas farmacológicas no ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::cdef12e4a96cefcac11fb52026a2accc
https://hdl.handle.net/11000/27668
https://hdl.handle.net/11000/27668
Autor:
Solano Lozano, María Dolores
La osteoporosis se define como una enfermedad ósea caracterizada por una disminución de la densidad del tejido óseo y tiene como consecuencia una fragilidad exagerada de los huesos. Esta enfermedad está relacionada en gran medida con la menopausi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3272::dd1246937a859d1fe4250e7ce0de4f88